Scheme 1From: Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapyA scheme illustration the preparation of the Cur loaded MnO2/HA for targeting delivery in atherosclerotic lesions, and the mechanisms for anti-AS therapyBack to article page